SEC Form 4 · accession 0001610717-26-000327
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven L. Cook
Officer — Chief Financial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 8, 2026 · 8:14 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | M | 23,263 | $8.28 | A | 210,472 | D | |
| Common StockF2 | Jul 1, 2026 | S | 23,263 | $22.7615 | D | 187,209 | D | |
| Common Stock | Jul 7, 2026 | M | 10,601 | $8.28 | A | 197,810 | D | |
| Common Stock | Jul 7, 2026 | M | 1,042 | $8.01 | A | 198,852 | D | |
| Common Stock | Jul 7, 2026 | M | 694 | $7.68 | A | 199,546 | D | |
| Common StockF3 | Jul 7, 2026 | S | 12,337 | $23.0883 | D | 187,209 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $8.28 | Jul 1, 2026 | M | 23,263 | D | — | Jul 19, 2031 | Common Stock | 23,263 | 278,246 | D |
| Stock Option (Right to Buy)F4 | $8.28 | Jul 7, 2026 | M | 10,601 | D | — | Jul 19, 2031 | Common Stock | 10,601 | 267,645 | D |
| Stock Option (Right to Buy)F5 | $8.01 | Jul 7, 2026 | M | 1,042 | D | — | Feb 8, 2034 | Common Stock | 1,042 | 19,792 | D |
| Stock Option (Right to Buy)F6 | $7.68 | Jul 7, 2026 | M | 694 | D | — | Jan 27, 2035 | Common Stock | 694 | 21,528 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F2This transaction was executed in multiple trades at prices ranging from $22.11 to $23.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $23.00 to $23.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4100% of the shares subject to the option are fully vested and exercisable.
- F51/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F61/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.